The University of Hong Kong: Hepatitis B trials
The registry lists 15 Hepatitis B studies with The University of Hong Kong as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 2 3Phase 3 3Phase 4 1No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Linkage to Care and Treatment of Chronic HBV PatientsCompletedNCT06658678Not applicable
- Detecting Occult HBV Infection in Liver Donors Positive for Antibody to Hepatitis B Core Antigen (Anti-HBc)Status unknownNCT04199819Not applicable
- Intra-dermal With Topical Imiquimod Pretreatment Versus Intra-muscular Hepatitis B Vaccination in IBD PatientsCompletedNCT04083157Phase 2/3
- Renoprotective Effects of Telbivudine in Chronic Hepatitis BCompletedNCT03778567Phase 4
- Quality of Life and Health Utility of Patients With CHB InfectionsCompletedNCT03329820
- ID HBV Vaccination With Imiquimod in OBICompletedNCT03307902Phase 2/3
- Optimizing HBV Management During Anti-CD20 AntibodiesCompletedNCT03155984
- Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus CarriersStatus unknownNCT02991638Phase 3
- Off Treatment Durability in Chronic Hepatitis B With Good Immune ControlCompletedNCT02738554Not applicable
- Evaluation of Paternal, Maternal and Obstetric Factors Leading to the Hepatitis B Immunization Failure in Hong KongCompletedNCT02443233
- Tenofovir in Asian Chronic Hepatitis B PatientsCompletedNCT01728935Not applicable
- Risk of Hepatitis B Reactivation in Patients With Prior HBV Exposure Undergoing Rituximab-containing Chemotherapy: A Prospective StudyCompletedNCT01502397
- Risk of Hepatitis B Reactivation After Bone Marrow Transplantation With Prior Hepatitis B Virus (HBV) ExposureCompletedNCT01481649
- Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral LoadCompletedNCT01013272Not applicable
- Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)CompletedNCT00804622Phase 2